Impact of chemoradiotherapy (CRT) on immune-related tumor microenvironment and the efficacy of anti-PD-1 therapy after the recurrence of CRT in unresectable locally advanced NSCLC patients.

Masayuki Shirasawa,Tatsuya Yoshida,Noriko Motoi,Yuji Matsumoto,Yuki Shinno,Yusuke Okuma,Yasushi Goto,Hidehito Horinouchi,Noboru Yamamoto,Shun-ichi Watanabe,Yuichiro Ohe

Impact of chemoradiotherapy (CRT) on immune-related tumor microenvironment and the efficacy of anti-PD-1 therapy after the recurrence of CRT in unresectable locally advanced NSCLC patients.

2020

Masayuki Shirasawa
Tatsuya Yoshida
Noriko Motoi
Yuji Matsumoto
Yuki Shinno
Yusuke Okuma
Yasushi Goto
Hidehito Horinouchi
Noboru Yamamoto
Shun-ichi Watanabe
Yuichiro Ohe

e21719Background: Chemoradiotherapy (CRT) followed by durvalumab as maintenance therapy prolonged progression-free survival (PFS) and overall survival (OS) in unresectable locally advanced NSCLC (L...

Keywords:

Oncology
Immune system
anti pd 1
Tumor microenvironment
locally advanced
Pathology
Internal medicine
Medicine
Chemoradiotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations